ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $640,586 | -22.0% | 105,882 | 0.0% | 0.00% | – |
| Q2 2023 | $821,644 | +765.6% | 105,882 | +535.8% | 0.00% | – |
| Q1 2023 | $94,922 | -3.2% | 16,653 | 0.0% | 0.00% | – |
| Q4 2022 | $98,086 | +81.6% | 16,653 | 0.0% | 0.00% | – |
| Q3 2022 | $54,000 | -91.7% | 16,653 | -88.5% | 0.00% | – |
| Q2 2022 | $647,000 | -43.8% | 144,317 | -33.0% | 0.00% | – |
| Q1 2022 | $1,151,000 | -65.1% | 215,513 | -4.0% | 0.00% | -100.0% |
| Q4 2021 | $3,300,000 | -28.2% | 224,431 | +2.2% | 0.00% | -50.0% |
| Q3 2021 | $4,593,000 | +98.4% | 219,655 | +67.9% | 0.00% | +100.0% |
| Q2 2021 | $2,315,000 | -17.5% | 130,815 | +14.2% | 0.00% | 0.0% |
| Q1 2021 | $2,806,000 | -24.4% | 114,503 | +4.4% | 0.00% | 0.0% |
| Q4 2020 | $3,714,000 | +180.7% | 109,713 | +107.5% | 0.00% | 0.0% |
| Q3 2020 | $1,323,000 | -27.0% | 52,876 | -1.6% | 0.00% | 0.0% |
| Q2 2020 | $1,813,000 | – | 53,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |